14th Annual Scientific Meeting Posters

Poster PDFs and abstracts are in alphabetical order by author.

Intrinsic Connectivity Networks in Posttraumatic Stress Disorder: A Systematic Graph Theory Approach (Abstract)

Akiki

Empirical Evaluation of the SIBAT Using Categories Established by 3 Versions of the C-CASA (Abstract)

Alphs

Foundations for a Patient-Reported Natural History of Early Parkinson Disease: Cross-Sectional Analysis of the MJFF Fox Insight Platform (Abstract)

Arbatti

Assessment of iADL Functioning in Individuals with Subjective Cognitive Complaints Using the VRFCAT (Abstract)

Atkins

Clinical Predictors of Antisuicidal Response to Ketamine (Abstract)

Ballard

Web-Based Computerised Cognitive Testing Using CANTAB: Comparison to In-Person Assessment (Abstract)

Cormack

Does Variation in the Time of Day of PANSS Assessment Affect Symptom Severity? (Abstract)

Daniel

The Rater Applied Performance Scale: Evaluating Clinical Interview Skill via Audio Recordings of MADRS Assessments (Abstract)

Engelhardt

A Phase 3 Study to Evaluate Pimavanserin for the Treatment of Dementia-Related Psychosis (Abstract)

Foff

Why Do Amyloid-Modulating Clinical Trials Fail in Alzheimer’s Disease? A Quantitative Systems Pharmacology Analysis (Abstract)

Geerts

Assessing the Value of an IA Platform to Predict Adherence in a Phase 2 Schizophrenia Study (Abstract)

Goeldner

Cognitive Assessment in Oncology Patients Reveals Age-Sensitive Attentional Impairment (Abstract)

Goetghebeur

Exploring Participant-Level Trajectories of Cognitive Performance in Schizophrenia (Abstract)

Granger

EEG Spectral Fingerprinting as a Method of Safeguarding Data Integrity in Multicenter Trials (Abstract)

Gruber

Can Subjects with Major Depression Learn About Placebo Response Factors? (Abstract)

Hassman

Cognitive Endpoints for Early Alzheimer’s Disease Trials: Development of the EMACC (Abstract)

Jaeger

Estimands in a Schizophrenia Study (Abstract)

Josiassen

PANSS Negative Symptom Dimensions Across Geographical Regions (Abstract)

Khan Anzalee

The Magnitude of Placebo Response Over Time in Clinical Trials (Abstract)

Khan-Arif

Reliability Findings from the Unified Global Training Program for the BNSS (Abstract)

Kirkpatrick

Association of PANSS Interview Duration with Data Quality (Abstract)

Kott

Engagement and Recruitment in the MOBILITY Trial (Abstract)

Lytle

A Double-Blinded RCT of Transcranial Direct Current Stimulation for Affective Symptoms (Abstract)

Mariano

Using Self-Reported Functioning Measures to Identify MDD Patients with Impaired Capacity (Abstract)

Murthy

Simplified Negative and Positive Symptoms Interview (SNAPSI) (Abstract)

Ostergaard

Utility of Human Laboratory Models for Screening Pharmacotherapeutics for Alcohol Use Disorder (Abstract)

Ramchandani

Developing Clinically Meaningful Responder Thresholds for Primary Endpoints (Abstract)

Revicki

Variation in Diagnostic Reliability Across MDD Clinical Trials (Abstract)

Sachs

Overcoming Obstacles to Implementation of a Clinical Trial on Chronic Psychotic Disorders in Tanzania (Abstract)

Sajatovic

Comparison Between Flat and Enhanced eCOA of MMSE Attention and Calculation (Abstract)

Seichepine

Dont Change the Subject! Changing Nature of Screened Subjects During Phase 3 Trials (Abstract)

Shiovitz

Evolution of Alzheimer’s Disease Trial Characteristics: 2000–2017 (Abstract)

Smigorski

Exploring Novel Behavioral Tasks and Digital Phenotyping Technologies (Abstract)

Smith

Global Regulatory Agencies Support Use of Dopamine Transporter Neuroimaging (Abstract)

Stephenson

Relationships Among CGI-S, MADRS, PHQ-9, and Sheehan Disability Scales (Abstract)

Turkoz

Use of a Prediction Algorithm for Randomized Stratification in ALS Study (Abstract)

VanMeter

Towards More Efficient Methods for COA Instrument Selection in Clinical Trials (Abstract)

Zaragoza Domingo